{
  "DOI": "10.1007/s10689-014-9743-2",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-014-9743-2",
  "alternative-id": [
    "9743"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Langabeer",
      "given": "Stephen E.",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Haslam",
      "given": "Karl",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Linders",
      "given": "Jennifer",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Percy",
      "given": "Melanie J.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Conneally",
      "given": "Eibhlin",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Hayat",
      "given": "Amjad",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Hennessy",
      "given": "Brian",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Leahy",
      "given": "Maeve",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Murphy",
      "given": "Karen",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Murray",
      "given": "Margaret",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ni Ainle",
      "given": "Fionnuala",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Thornton",
      "given": "Patrick",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Sargent",
      "given": "Jeremy",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2014,
        8,
        7
      ]
    ],
    "date-time": "2014-08-07T09:24:35Z",
    "timestamp": 1407403475000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        5,
        30
      ]
    ],
    "date-time": "2019-05-30T21:46:14Z",
    "timestamp": 1559252774000
  },
  "indexed": {
    "date-parts": [
      [
        2022,
        3,
        30
      ]
    ],
    "date-time": "2022-03-30T13:32:38Z",
    "timestamp": 1648647158358
  },
  "is-referenced-by-count": 4,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "4",
  "issued": {
    "date-parts": [
      [
        2014,
        8,
        8
      ]
    ]
  },
  "journal-issue": {
    "issue": "4",
    "published-print": {
      "date-parts": [
        [
          2014,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2014,
            8,
            8
          ]
        ],
        "date-time": "2014-08-08T00:00:00Z",
        "timestamp": 1407456000000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-014-9743-2.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-014-9743-2/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-014-9743-2",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "659-663",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2014,
        8,
        8
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2014,
        8,
        8
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2014,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1200/JCO.2010.29.8711",
      "author": "A Tefferi",
      "doi-asserted-by": "crossref",
      "first-page": "573",
      "journal-title": "J Clin Oncol",
      "key": "9743_CR1",
      "unstructured": "Tefferi A, Vainchenker W (2011) Myeloproliferative neoplasms: molecular pathophysiology, essential clinical understanding, and treatment strategies. J Clin Oncol 29:573–582",
      "volume": "29",
      "year": "2011"
    },
    {
      "author": "B McMahon",
      "first-page": "101",
      "journal-title": "Semin Thromb Hemost",
      "key": "9743_CR2",
      "unstructured": "McMahon B, Stein BL (2013) Thrombotic and bleeding complications in classical myeloproliferative neoplasms. Semin Thromb Hemost 39:101–111",
      "volume": "39",
      "year": "2013"
    },
    {
      "DOI": "10.1038/nrc2210",
      "author": "RL Levine",
      "doi-asserted-by": "crossref",
      "first-page": "673",
      "journal-title": "Nat Rev Cancer",
      "key": "9743_CR3",
      "unstructured": "Levine RL, Pardanani A, Tefferi A, Gilliland DG (2007) Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders. Nat Rev Cancer 7:673–683",
      "volume": "7",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.hoc.2012.07.008",
      "author": "FP Santos",
      "doi-asserted-by": "crossref",
      "first-page": "1083",
      "journal-title": "Hematol Oncol Clin North Am",
      "key": "9743_CR4",
      "unstructured": "Santos FP, Verstovsek S (2012) Therapy with JAK2 inhibitors for myeloproliferative neoplasms. Hematol Oncol Clin North Am 26:1083–1099",
      "volume": "26",
      "year": "2012"
    },
    {
      "DOI": "10.1056/NEJMoa065202",
      "author": "LM Scott",
      "doi-asserted-by": "crossref",
      "first-page": "459",
      "journal-title": "N Engl J Med",
      "key": "9743_CR5",
      "unstructured": "Scott LM, Tong W, Levine RL et al (2007) JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis. N Engl J Med 356:459–468",
      "volume": "356",
      "year": "2007"
    },
    {
      "DOI": "10.1056/NEJMoa1311347",
      "author": "T Klampfl",
      "doi-asserted-by": "crossref",
      "first-page": "2379",
      "journal-title": "N Engl J Med",
      "key": "9743_CR6",
      "unstructured": "Klampfl T, Gisslinger H, Harutyunyan AS et al (2013) Somatic mutations of calreticulin in myeloproliferative neoplasms. N Engl J Med 369:2379–2390",
      "volume": "369",
      "year": "2013"
    },
    {
      "DOI": "10.1056/NEJMoa1312542",
      "author": "J Nangalia",
      "doi-asserted-by": "crossref",
      "first-page": "2391",
      "journal-title": "N Engl J Med",
      "key": "9743_CR7",
      "unstructured": "Nangalia J, Massie CE, Baxter EJ et al (2013) Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. N Engl J Med 369:2391–2405",
      "volume": "369",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.jmoldx.2013.07.002",
      "author": "JZ Gong",
      "doi-asserted-by": "crossref",
      "first-page": "733",
      "journal-title": "J Mol Diagn",
      "key": "9743_CR8",
      "unstructured": "Gong JZ, Cook JR, Greiner TC et al (2013) Laboratory practice guidelines for detecting and reporting JAK2 and MPL mutations in myeloproliferative neoplasms: a report from the Association for Molecular Pathology. J Mol Diagn 15:733–744",
      "volume": "15",
      "year": "2013"
    },
    {
      "DOI": "10.1038/leu.2010.69",
      "author": "A Tefferi",
      "doi-asserted-by": "crossref",
      "first-page": "1128",
      "journal-title": "Leukemia",
      "key": "9743_CR9",
      "unstructured": "Tefferi A (2010) Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1. Leukemia 24:1128–1138",
      "volume": "24",
      "year": "2010"
    },
    {
      "DOI": "10.1002/hon.863",
      "author": "E Rumi",
      "doi-asserted-by": "crossref",
      "first-page": "131",
      "journal-title": "Hematol Oncol",
      "key": "9743_CR10",
      "unstructured": "Rumi E (2008) Familial chronic myeloproliferative disorders: the state of the art. Hematol Oncol 26:131–138",
      "volume": "26",
      "year": "2008"
    },
    {
      "DOI": "10.1016/j.bcmd.2012.06.004",
      "author": "S Malak",
      "doi-asserted-by": "crossref",
      "first-page": "170",
      "journal-title": "Blood Cells Mol Dis",
      "key": "9743_CR11",
      "unstructured": "Malak S, Labopin M, Saint-Martin C, Bellanne-Chantelot C, Najman A (2012) Long term follow up of 93 families with myeloproliferative neoplasms: life expectancy and implications of JAK2 V617F in the occurrence of complications. Blood Cells Mol Dis 49:170–176",
      "volume": "49",
      "year": "2012"
    },
    {
      "DOI": "10.1111/cge.12044",
      "author": "A Ranjan",
      "doi-asserted-by": "crossref",
      "first-page": "99",
      "journal-title": "Clin Genet",
      "key": "9743_CR12",
      "unstructured": "Ranjan A, Penninga E, Jelsig AM, Hasselbalch H, Bjerrum OW (2013) Inheritance of the chronic myeloproliferative neoplasms: a systematic review. Clin Genet 83:99–107",
      "volume": "83",
      "year": "2013"
    },
    {
      "DOI": "10.1002/humu.22448",
      "author": "C Bento",
      "doi-asserted-by": "crossref",
      "first-page": "15",
      "journal-title": "Hum Mutat",
      "key": "9743_CR13",
      "unstructured": "Bento C, Percy MJ, Gardie B et al (2014) Genetic basis of congenital erythrocytosis: mutation update and online databases. Hum Mutat 35:15–26",
      "volume": "35",
      "year": "2014"
    },
    {
      "DOI": "10.3324/haematol.2009.015941",
      "author": "RC Skoda",
      "doi-asserted-by": "crossref",
      "first-page": "6",
      "journal-title": "Haematologica",
      "key": "9743_CR14",
      "unstructured": "Skoda RC (2010) Hereditary myeloproliferative disorders. Haematologica 95:6–8",
      "volume": "95",
      "year": "2010"
    },
    {
      "DOI": "10.1056/NEJMc1200349",
      "author": "AJ Mead",
      "doi-asserted-by": "crossref",
      "first-page": "967",
      "journal-title": "N Engl J Med",
      "key": "9743_CR15",
      "unstructured": "Mead AJ, Rugless MJ, Jacobsen SE, Schuh A (2012) Germline JAK2 mutation in a family with hereditary thrombocytosis. N Engl J Med 366:967–969",
      "volume": "366",
      "year": "2012"
    },
    {
      "DOI": "10.1038/ng.334",
      "author": "AV Jones",
      "doi-asserted-by": "crossref",
      "first-page": "446",
      "journal-title": "Nat Genet",
      "key": "9743_CR16",
      "unstructured": "Jones AV, Chase A, Silver RT et al (2009) JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms. Nat Genet 41:446–449",
      "volume": "41",
      "year": "2009"
    },
    {
      "DOI": "10.1038/ng.341",
      "author": "D Olcaydu",
      "doi-asserted-by": "crossref",
      "first-page": "450",
      "journal-title": "Nat Genet",
      "key": "9743_CR17",
      "unstructured": "Olcaydu D, Harutyunyan A, Jäger R et al (2009) A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms. Nat Genet 41:450–454",
      "volume": "41",
      "year": "2009"
    },
    {
      "DOI": "10.1038/ng.342",
      "author": "O Kilpivaara",
      "doi-asserted-by": "crossref",
      "first-page": "455",
      "journal-title": "Nat Genet",
      "key": "9743_CR18",
      "unstructured": "Kilpivaara O, Mukherjee S, Schram AM et al (2009) A germline SNP is associated with predisposition to the development of JAK2 (V617F)-positive myeloproliferative neoplasms. Nat Genet 41:455–459",
      "volume": "41",
      "year": "2009"
    },
    {
      "DOI": "10.1038/leu.2009.110",
      "author": "D Olcaydu",
      "doi-asserted-by": "crossref",
      "first-page": "1924",
      "journal-title": "Leukemia",
      "key": "9743_CR19",
      "unstructured": "Olcaydu D, Skoda RC, Looser R et al (2009) The GGCC haplotype of JAK2 confers susceptibility to JAK2 exon 12 mutation-positive polycythemia vera. Leukemia 23:1924–1926",
      "volume": "23",
      "year": "2009"
    },
    {
      "DOI": "10.1182/blood-2009-08-236448",
      "author": "AV Jones",
      "doi-asserted-by": "crossref",
      "first-page": "4517",
      "journal-title": "Blood",
      "key": "9743_CR20",
      "unstructured": "Jones AV, Campbell PJ, Beer PA et al (2010) The JAK2 46/1 haplotype predisposes to MPL-mutated myeloproliferative neoplasms. Blood 115:4517–4523",
      "volume": "115",
      "year": "2010"
    },
    {
      "key": "9743_CR21",
      "unstructured": "Swerdlow SH, Campo E, Harris NL et al (eds) (2008) WHO classification of tumours of haematopoietic and lymphoid tissue. International Agency for Research on Cancer, Lyon",
      "volume-title": "WHO classification of tumours of haematopoietic and lymphoid tissue",
      "year": "2008"
    },
    {
      "DOI": "10.1016/S0140-6736(05)71142-9",
      "author": "EJ Baxter",
      "doi-asserted-by": "crossref",
      "first-page": "1054",
      "journal-title": "Lancet",
      "key": "9743_CR22",
      "unstructured": "Baxter EJ, Scott LM, Campbell PJ et al (2005) Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 365:1054–1061",
      "volume": "365",
      "year": "2005"
    },
    {
      "DOI": "10.1159/000224333",
      "author": "S Daly",
      "doi-asserted-by": "crossref",
      "first-page": "221",
      "journal-title": "Acta Haematol",
      "key": "9743_CR23",
      "unstructured": "Daly S, Conneally E, Langabeer SE (2009) Identification of the MPL W515L/K mutations in patients with primary myelofibrosis and essential thrombocythaemia by allele-specific polymerase chain reaction. Acta Haematol 121:221–222",
      "volume": "121",
      "year": "2009"
    },
    {
      "DOI": "10.3324/haematol.11643",
      "author": "MJ Percy",
      "doi-asserted-by": "crossref",
      "first-page": "1607",
      "journal-title": "Haematologica",
      "key": "9743_CR24",
      "unstructured": "Percy MJ, Scott LM, Erber WN et al (2007) The frequency of JAK2 exon 12 mutations in idiopathic erythrocytosis patients with low serum erythropoietin levels. Haematologica 92:1607–1614",
      "volume": "92",
      "year": "2007"
    },
    {
      "DOI": "10.1007/s00277-012-1502-6",
      "author": "L Martinez-Avilés",
      "doi-asserted-by": "crossref",
      "first-page": "1555",
      "journal-title": "Ann Hematol",
      "key": "9743_CR25",
      "unstructured": "Martinez-Avilés L, Álvarez-Larrán A, Besses C et al (2012) Clinical significance of clonality assessment in JAK2 V617F-negative essential thrombocythemia. Ann Hematol 91:1555–1562",
      "volume": "91",
      "year": "2012"
    },
    {
      "author": "K Hussein",
      "journal-title": "Eur J Hum Genet",
      "key": "9743_CR26",
      "unstructured": "Hussein K, Percy M, McMullin MF et al (2014) Clinical utility gene card for: hereditary thrombocythemia. Eur J Hum Genet. doi: 10.1038/ejhg.2013.117",
      "year": "2014"
    },
    {
      "DOI": "10.1038/leu.2014.33",
      "author": "M Maffioli",
      "doi-asserted-by": "crossref",
      "first-page": "1357",
      "journal-title": "Leukemia",
      "key": "9743_CR27",
      "unstructured": "Maffioli M, Genoni A, Caramazza D et al (2014) Looking for CALR mutations in familial myeloproliferative disorders. Leukemia 28:1357–1360",
      "volume": "28",
      "year": "2014"
    },
    {
      "DOI": "10.1182/blood-2014-01-550434",
      "author": "E Rumi",
      "doi-asserted-by": "crossref",
      "first-page": "2416",
      "journal-title": "Blood",
      "key": "9743_CR28",
      "unstructured": "Rumi E, Harutyunyan AS, Pietra D et al (2014) CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosis. Blood 123:2416–2419",
      "volume": "123",
      "year": "2014"
    },
    {
      "DOI": "10.1002/ajh.23614",
      "author": "E Rumi",
      "doi-asserted-by": "crossref",
      "first-page": "117",
      "journal-title": "Am J Hematol",
      "key": "9743_CR29",
      "unstructured": "Rumi E, Harutyunyan AS, Casetti I et al (2014) A novel germline JAK2 mutation in familial myeloproliferative neoplasms. Am J Hematol 89:117–118",
      "volume": "89",
      "year": "2014"
    },
    {
      "DOI": "10.1182/blood-2012-12-473777",
      "author": "SL Etheridge",
      "doi-asserted-by": "crossref",
      "first-page": "1059",
      "journal-title": "Blood",
      "key": "9743_CR30",
      "unstructured": "Etheridge SL, Cosgrove ME, Sangkhae V et al (2014) A novel activating, germline JAK2 mutation, JAK2 R564Q, causes familial essential thrombocytosis. Blood 123:1059–1068",
      "volume": "123",
      "year": "2014"
    },
    {
      "DOI": "10.1200/JCO.2007.12.6896",
      "author": "E Rumi",
      "doi-asserted-by": "crossref",
      "first-page": "5630",
      "journal-title": "J Clin Oncol",
      "key": "9743_CR31",
      "unstructured": "Rumi E, Passamonti F, Della Porta MG et al (2007) Familial chronic myeloproliferative disorders: clinical phenotype and evidence of disease anticipation. J Clin Oncol 35:5630–5635",
      "volume": "35",
      "year": "2007"
    },
    {
      "DOI": "10.3324/haematol.2010.034488",
      "author": "D Olcaydu",
      "doi-asserted-by": "crossref",
      "first-page": "367",
      "journal-title": "Haematologica",
      "key": "9743_CR32",
      "unstructured": "Olcaydu D, Rumi E, Harutyunyan A et al (2011) The role of the JAK2 GGCC haplotype and the TET2 gene in familial myeloproliferative neoplasms. Haematologica 96:367–374",
      "volume": "96",
      "year": "2011"
    },
    {
      "DOI": "10.1002/ajh.23243",
      "author": "LM Scott",
      "doi-asserted-by": "crossref",
      "first-page": "1028",
      "journal-title": "Am J Hematol",
      "key": "9743_CR33",
      "unstructured": "Scott LM, Rebel VI (2012) JAK2 and genomic instability in the myeloproliferative neoplasms: a case of the chicken or the egg? Am J Hematol 87:1028–1036",
      "volume": "87",
      "year": "2012"
    },
    {
      "DOI": "10.1002/ajh.22212",
      "author": "LA Anderson",
      "doi-asserted-by": "crossref",
      "first-page": "175",
      "journal-title": "Am J Hematol",
      "key": "9743_CR34",
      "unstructured": "Anderson LA, Duncombe AS, Hughes M et al (2012) Environmental, lifestyle, and familial/ethnic factors associated with myeloproliferative neoplasms. Am J Hematol 87:175–182",
      "volume": "87",
      "year": "2012"
    },
    {
      "DOI": "10.1177/2040620713489144",
      "author": "AV Jones",
      "doi-asserted-by": "crossref",
      "first-page": "237",
      "journal-title": "Ther Adv Hematol",
      "key": "9743_CR35",
      "unstructured": "Jones AV, Cross NCP (2013) Inherited predisposition to myeloproliferative neoplasms. Ther Adv Hematol 4:237–253",
      "volume": "4",
      "year": "2013"
    }
  ],
  "reference-count": 35,
  "references-count": 35,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-014-9743-2"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Molecular heterogeneity of familial myeloproliferative neoplasms revealed by analysis of the commonly acquired JAK2, CALR and MPL mutations"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "13"
}